Home

About

Advanced Search

Browse by Discipline

Scientific Societies

E-print Alerts

Add E-prints

E-print Network
FAQHELPSITE MAPCONTACT US


  Advanced Search  

 
Applied Pharmacoeconomic and Outcomes Research Forum The second Southern California Applied Pharmacoeconomic and Outcomes Research Forum
 

Summary: Applied Pharmacoeconomic and Outcomes Research Forum
Fall 2006
REPORT
The second Southern California Applied Pharmacoeconomic and Outcomes Research Forum
was held October 16th
on the University of California San Diego campus. The event was hosted
by the Skaggs School of Pharmacy and Pharmaceutical Sciences and supported by a grant
from Allergan.
Attendees of the Forum represented Managed Care Organizations, Government Agencies,
Medical Centers, Academia, and Pharmaceutical and Biotech companies in Southern California.
Each attendee was invited because they had a demonstrated interest in expanding the practical
application of pharmacoeconomic and outcomes research to enhance decision-making.
Topic
"Biologics: Drawing (or Crossing) the line of Cost vs. Benefit? A Case in Oncology
The case, prepared by Margaret Stull, PharmD, Pharmacoeconomic Clinical Specialist at the
VA San Diego Healthcare System, was for a hypothetical new biologic agent - Expenzumab
(VegitinTM) - indicated for first-line treatment of metastatic colorectal carcinomas.
Perspective Views
Three speakers commented from their institution's perspective regarding issues they may face if
evaluating and managing Expenzumab within their health care system.

  

Source: Abagyan, Ruben - School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego

 

Collections: Biology and Medicine